CAS: 1438416-21-7 - 2,5-Dioxopyrrolidin-1-yl 4-[bis(4-chlorophenyl)methyl]piperazine-1-carboxylate
Formula:C22H21Cl2N3O4
InChI:InChI=1S/C22H21Cl2N3O4/c23-17-5-1-15(2-6-17)21(16-3-7-18(24)8-4-16)25-11-13-26(14-12-25)22(30)31-27-19(28)9-10-20(27)29/h1-8,21H,9-14H2
InChI key:InChIKey=BEADRWVIFHOSGN-UHFFFAOYSA-N
SMILES:O=C(ON1C(=O)CCC1=O)N2CCN(CC2)C(C3=CC=C(Cl)C=C3)C4=CC=C(Cl)C=C4
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
MJN110 REF: TM-T5815CAS: 1438416-21-7 | 98% | 51.00 €~487.00 € | Fri 13 Dec 24 | |
MJN110 REF: 3D-NHC41621CAS: 1438416-21-7 | Min. 95% | To inquire | Fri 17 Jan 25 | |
Cravatt Reagent REF: IN-DA00ASEZCAS: 1438416-21-7 | 98% | - - - | Discontinued product |
MJN110
CAS:1438416-21-7
MJN110 (Cravatt Reagent) is a potent and selective MAGL inhibitor. MJN110 Produces Opioid-Sparing Effects in …
Formula:
C22H21Cl2N3O4
Purity:
98%
Color and Shape:
Solid
Molecular weight:
462.33
Ref: TM-T5815
5mg | 51.00 € | ||
10mg | 86.00 € | ||
25mg | 167.00 € | ||
50mg | 271.00 € | ||
100mg | 487.00 € | ||
1mL*10mM (DMSO) | 52.00 € |
Estimated delivery in United States, on Friday 13 Dec 2024
MJN110
CAS:1438416-21-7
MJN110 is a novel drug that inhibits the activity of fatty acid amide hydrolase (FAAH), …
Formula:
C22H21Cl2N3O4
Purity:
Min. 95%
Molecular weight:
462.33 g/mol
Ref: 3D-NHC41621
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Friday 17 Jan 2025
Cravatt Reagent
CAS:1438416-21-7
Formula:
C22H21Cl2N3O4
Purity:
98%
Color and Shape:
Solid
Molecular weight:
462.3258
Ref: IN-DA00ASEZ
1mg | Discontinued | Request information | |
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information |